What is ICU's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.02B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ICU?

P/E (TTM) is n/a and 52-week range is $2.07 to $7.35 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ICU figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ICU?

The company profile lists revenue (TTM) near $2M, net income (TTM) near $-1.33B, EPS (TTM) near $-3.93 when available from the market-data feed. Figures are informational and may lag live markets.

Where is SeaStar Medical Holding Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Denver, Colorado, US, 4M shares outstanding, ISIN US81256L3024 when available from company profile and filing metadata.

Chartloom

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, Colorado and currently employs 17 full-time employees. The company went IPO on 2021-01-26. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. The company has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Employees

Website

seastarmedical.com

IPO

2021-01-26

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)